{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T14:34:02Z","timestamp":1776782042540,"version":"3.51.2"},"reference-count":41,"publisher":"e-Century Publishing Corporation","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Exp Pathol"],"DOI":"10.62347\/cxdc6773","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T03:38:41Z","timestamp":1737430721000},"page":"12-22","source":"Crossref","is-referenced-by-count":3,"title":["Effects of serum HIF-1α, VEGF, and uPA levels on clinicopathologic findings and prognosis in oral squamous cell carcinoma"],"prefix":"10.62347","volume":"18","author":[{"given":"Kedan","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","article-title":"Head and neck squamous cell carcinoma","volume":"6","author":"Johnson","year":"2020","unstructured":"Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE and Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Primers 2020; 6: 92.","journal-title":"Nat Rev Dis Primers"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"13081","DOI":"10.1038\/s41598-018-31498-z","article-title":"Nomogram based on albumin and neutrophil-to-lymphocyte ratio for predicting the prognosis of patients with oral cavity squamous cell carcinoma","volume":"8","author":"HK","year":"2018","unstructured":"Kao HK, Löfstrand J, Loh CY, Lao WW, Yi JS, Chang YL and Chang KP. Nomogram based on albumin and neutrophil-to-lymphocyte ratio for predicting the prognosis of patients with oral cavity squamous cell carcinoma. Sci Rep 2018; 8: 13081.","journal-title":"Sci Rep"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.oraloncology.2019.07.015","article-title":"Impact of dysplastic surgical margins for patients with oral squamous cell carcinoma","volume":"97","author":"Chen","year":"2019","unstructured":"Chen TC, Chang HL, Yang TL, Lou PJ, Chang YL, Ko JY and Wang CP. Impact of dysplastic surgical margins for patients with oral squamous cell carcinoma. Oral Oncol 2019; 97: 1-6.","journal-title":"Oral Oncol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3390\/biology10080760","article-title":"Survival-based biomarker module identification associated with oral squamous cell carcinoma (OSCC)","volume":"10","author":"Singh","year":"2021","unstructured":"Singh P, Rai A, Verma AK, Alsahli MA, Rahmani AH, Almatroodi SA, Alrumaihi F, Dev K, Sinha A, Sankhwar S and Dohare R. Survival-based biomarker module identification associated with oral squamous cell carcinoma (OSCC). Biology (Basel) 2021; 10: 760.","journal-title":"Biology (Basel)"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.yexcr.2012.12.010","article-title":"The hypoxic tumor microenvironment regulates invasion of aggressive oral carcinoma cells","volume":"319","author":"Teppo","year":"2013","unstructured":"Teppo S, Sundquist E, Vered M, Holappa H, Parkkisenniemi J, Rinaldi T, Lehenkari P, Grenman R, Dayan D, Risteli J, Salo T and Nyberg P. The hypoxic tumor microenvironment regulates invasion of aggressive oral carcinoma cells. Exp Cell Res 2013; 319: 376-389.","journal-title":"Exp Cell Res"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1002\/cam4.1489","article-title":"Prognostic significance of combined pretreatment lymphocyte counts and body mass index in patients with head and neck cancer treated with radiation therapy","volume":"7","author":"YY","year":"2018","unstructured":"Wu YY, Chang KP, Lin CY, Pai PC, Wang HM, Hsu CL, Liao CT, Yen TC, Fang TJ, Huang SF, Kang CJ, Fang KH, Lin WN, Wang YC, Hsin LJ and Tsang NM. Prognostic significance of combined pretreatment lymphocyte counts and body mass index in patients with head and neck cancer treated with radiation therapy. Cancer Med 2018; 7: 2808-2815.","journal-title":"Cancer Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"174820","DOI":"10.1016\/j.ejphar.2022.174820","article-title":"miR-340-5p affects oral squamous cell carcinoma (OSCC) cells proliferation and invasion by targeting endoplasmic reticulum stress proteins","volume":"920","author":"Ou","year":"2022","unstructured":"Ou D, Wu Y, Zhang J, Liu J, Liu Z, Shao M, Guo X and Cui S. miR-340-5p affects oral squamous cell carcinoma (OSCC) cells proliferation and invasion by targeting endoplasmic reticulum stress proteins. Eur J Pharmacol 2022; 920: 174820.","journal-title":"Eur J Pharmacol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1186\/s12967-021-03181-x","article-title":"Cancer-associated fibroblasts promote oral squamous cell carcinoma progression through LOX-mediated matrix stiffness","volume":"19","author":"Zhang","year":"2021","unstructured":"Zhang JY, Zhu WW, Wang MY, Zhai RD, Wang Q, Shen WL and Liu LK. Cancer-associated fibroblasts promote oral squamous cell carcinoma progression through LOX-mediated matrix stiffness. J Transl Med 2021; 19: 513.","journal-title":"J Transl Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1097\/SCS.0b013e3181d878d1","article-title":"Management of clinically negative neck in maxillary carcinoma","volume":"21","author":"Valentini","year":"2010","unstructured":"Valentini V, Terenzi V, Battisti A, Cassoni A, Anelli A, Priore P and Petrinca P. Management of clinically negative neck in maxillary carcinoma. J Craniofac Surg 2010; 21: 759-762.","journal-title":"J Craniofac Surg"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Gholami S, Chamorro-Petronacci C, Pérez-Sayáns M, Suárez Peñaranda J, Longatto-Filho A, Baltazar F and Afonso J. Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: a pilot study. J Appl Oral Sci 2023; 31: e20220461.","DOI":"10.1590\/1678-7757-2022-0461"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.21037\/atm-22-109","article-title":"Prognostic significance of serum tumor marker normalization in the perioperative period for patients with advanced gastric cancer","volume":"10","author":"Hu","year":"2022","unstructured":"Hu C, Zhang Y, Xu J, Chen W, Yu P, Wang Y, Bao Z, Zhang R, Xu Z and Cheng X. Prognostic significance of serum tumor marker normalization in the perioperative period for patients with advanced gastric cancer. Ann Transl Med 2022; 10: 153.","journal-title":"Ann Transl Med"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.1038\/s41598-020-80785-1","article-title":"A prognostic model for colorectal cancer based on CEA and a 48-multiplex serum biomarker panel","volume":"11","author":"Bj&#xF6","year":"2021","unstructured":"Björkman K, Jalkanen S, Salmi M, Mustonen H, Kaprio T, Kekki H, Pettersson K, Böckelman C and Haglund C. A prognostic model for colorectal cancer based on CEA and a 48-multiplex serum biomarker panel. Sci Rep 2021; 11: 4287.","journal-title":"Sci Rep"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.3390\/biom12101354","article-title":"Pulmonary thrombosis promotes tumorigenesis via myeloid hypoxia-inducible factors","volume":"12","author":"Lu","year":"2022","unstructured":"Lu X, Prodger A, Sim J and Evans CE. Pulmonary thrombosis promotes tumorigenesis via myeloid hypoxia-inducible factors. Biomolecules 2022; 12: 1354.","journal-title":"Biomolecules"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/cas.13483","article-title":"Regulatory mechanisms of hypoxia-inducible factor 1 activity: two decades of knowledge","volume":"109","author":"Koyasu","year":"2018","unstructured":"Koyasu S, Kobayashi M, Goto Y, Hiraoka M and Harada H. Regulatory mechanisms of hypoxia-inducible factor 1 activity: two decades of knowledge. Cancer Sci 2018; 109: 560-571.","journal-title":"Cancer Sci"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"106400","DOI":"10.1016\/j.bioorg.2023.106400","article-title":"Advances in antitumor research of HIF-1α inhibitor YC-1 and its derivatives","volume":"133","author":"Ouyang","year":"2023","unstructured":"Ouyang C, Zhang J, Lei X, Xie Z, Liu X, Li Y, Huang S, Wang Z and Tang G. Advances in antitumor research of HIF-1α inhibitor YC-1 and its derivatives. Bioorg Chem 2023; 133: 106400.","journal-title":"Bioorg Chem"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1073\/pnas.1320243111","article-title":"Transcriptional activation of hypoxia-inducible factor-1 (HIF-1) in myeloid cells promotes angiogenesis through VEGF and S100A8","volume":"111","author":"Ahn","year":"2014","unstructured":"Ahn GO, Seita J, Hong BJ, Kim YE, Bok S, Lee CJ, Kim KS, Lee JC, Leeper NJ, Cooke JP, Kim HJ, Kim IH, Weissman IL and Brown JM. Transcriptional activation of hypoxia-inducible factor-1 (HIF-1) in myeloid cells promotes angiogenesis through VEGF and S100A8. Proc Natl Acad Sci U S A 2014; 111: 2698-2703.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"3630","DOI":"10.3390\/cancers12123630","article-title":"Silencing of VEGFR2 by RGD-modified lipid nanoparticles enhanced the efficacy of anti-PD-1 antibody by accelerating vascular normalization and infiltration of T cells in tumors","volume":"12","author":"Cho","year":"2020","unstructured":"Cho R, Sakurai Y, Jones HS, Akita H, Hisaka A and Hatakeyama H. Silencing of VEGFR2 by RGD-modified lipid nanoparticles enhanced the efficacy of anti-PD-1 antibody by accelerating vascular normalization and infiltration of T cells in tumors. Cancers (Basel) 2020; 12: 3630.","journal-title":"Cancers (Basel)"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"535","DOI":"10.4161\/cam.22243","article-title":"VEGF-initiated angiogenesis and the uPA\/uPAR system","volume":"6","author":"Breuss","year":"2012","unstructured":"Breuss JM and Uhrin P. VEGF-initiated angiogenesis and the uPA\/uPAR system. Cell Adh Migr 2012; 6: 535-615.","journal-title":"Cell Adh Migr"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13550-020-00673-7","article-title":"Molecular imaging of the urokinase plasminogen activator receptor: opportunities beyond cancer","volume":"10","author":"Baart","year":"2020","unstructured":"Baart VM, Houvast RD, de Geus-Oei LF, Quax PHA, Kuppen PJK, Vahrmeijer AL and Sier CFM. Molecular imaging of the urokinase plasminogen activator receptor: opportunities beyond cancer. EJNMMI Res 2020; 10: 87.","journal-title":"EJNMMI Res"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1159\/000524653","article-title":"Predicted fat mass, lean body mass, and risk of hypertension: results from a Chinese male cohort study","volume":"15","author":"Li","year":"2022","unstructured":"Li M, Lin J, Liang S, Huang S, Wen Z and Mo Z. Predicted fat mass, lean body mass, and risk of hypertension: results from a Chinese male cohort study. Obes Facts 2022; 15: 638-647.","journal-title":"Obes Facts"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3389\/fneur.2020.00276","article-title":"Association of carotid atherosclerosis with lipid components in asymptomatic low-income Chinese: a population-based cross-sectional study","volume":"11","author":"Pan","year":"2020","unstructured":"Pan J, Liu J, Wang H, Li W, Du X, Lin Q, Zhang X, Qi D, Tu J, Ning X, Yang Q and Wang J. Association of carotid atherosclerosis with lipid components in asymptomatic low-income Chinese: a population-based cross-sectional study. Front Neurol 2020; 11: 276.","journal-title":"Front Neurol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3390\/cancers15010322","article-title":"Discovering the clinical and prognostic role of pan-immune-inflammation values on oral cavity squamous cell carcinoma","volume":"15","author":"Yeh","year":"2023","unstructured":"Yeh CC, Kao HK, Huang Y, Tsai TY, Young CK, Hung SY, Lu CY and Chang KP. Discovering the clinical and prognostic role of pan-immune-inflammation values on oral cavity squamous cell carcinoma. Cancers (Basel) 2023; 15: 322.","journal-title":"Cancers (Basel)"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s11864-017-0484-y","article-title":"Overview of the 8th edition TNM classification for head and neck cancer","volume":"18","author":"Huang","year":"2017","unstructured":"Huang SH and O’Sullivan B. Overview of the 8th edition TNM classification for head and neck cancer. Curr Treat Options Oncol 2017; 18: 40.","journal-title":"Curr Treat Options Oncol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"971275","DOI":"10.3389\/fcell.2022.971275","article-title":"Editorial: tumor microenvironment (TME) and tumor immune microenvironment (TIME): new perspectives for prognosis and therapy","volume":"10","author":"Ramos","year":"2022","unstructured":"Ramos RN, Amano MT, Paes Leme AF, Fox JW and de Oliveira AK. Editorial: tumor microenvironment (TME) and tumor immune microenvironment (TIME): new perspectives for prognosis and therapy. Front Cell Dev Biol 2022; 10: 971275.","journal-title":"Front Cell Dev Biol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10555-011-9270-7","article-title":"Tumor immunosurveillance in human cancers","volume":"30","author":"Mlecnik","year":"2011","unstructured":"Mlecnik B, Bindea G, Pagès F and Galon J. Tumor immunosurveillance in human cancers. Cancer Metastasis Rev 2011; 30: 5-12.","journal-title":"Cancer Metastasis Rev"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1186\/s12885-020-07566-x","article-title":"Anti-tumor efficacy of CKD-516 in combination with radiation in xenograft mouse model of lung squamous cell carcinoma","volume":"20","author":"Kim","year":"2020","unstructured":"Kim MY, Shin JY, Kim JO, Son KH, Kim YS, Jung CK and Kang JH. Anti-tumor efficacy of CKD-516 in combination with radiation in xenograft mouse model of lung squamous cell carcinoma. BMC Cancer 2020; 20: 1057.","journal-title":"BMC Cancer"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"6775496","DOI":"10.1155\/2022\/6775496","article-title":"Identification of a hypoxia-related lncRNA biomarker signature for head and neck squamous cell carcinoma","volume":"2022","author":"Yang","year":"2022","unstructured":"Yang C and Zheng X. Identification of a hypoxia-related lncRNA biomarker signature for head and neck squamous cell carcinoma. J Oncol 2022; 2022: 6775496.","journal-title":"J Oncol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.7150\/ijbs.70292","article-title":"Emerging roles of lncRNA in nasopharyngeal carcinoma and therapeutic opportunities","volume":"18","author":"Wang","year":"2022","unstructured":"Wang H, Wang W and Fan S. Emerging roles of lncRNA in nasopharyngeal carcinoma and therapeutic opportunities. Int J Biol Sci 2022; 18: 2714-2728.","journal-title":"Int J Biol Sci"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40169-019-0234-9","article-title":"Clinical applications of fucoidan in translational medicine for adjuvant cancer therapy","volume":"8","author":"Hsu","year":"2019","unstructured":"Hsu HY and Hwang PA. Clinical applications of fucoidan in translational medicine for adjuvant cancer therapy. Clin Transl Med 2019; 8: 15.","journal-title":"Clin Transl Med"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"682932","DOI":"10.3389\/fonc.2021.682932","article-title":"A prognostic DNA damage repair genes signature and its impact on immune cell infiltration in glioma","volume":"11","author":"Wang","year":"2021","unstructured":"Wang G, Zhou H, Tian L, Yan T, Han X, Chen P, Li H, Wang W, Xiao Z, Hou L and Xue X. A prognostic DNA damage repair genes signature and its impact on immune cell infiltration in glioma. Front Oncol 2021; 11: 682932.","journal-title":"Front Oncol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fonc.2018.00024","article-title":"Multifaceted role of the urokinase-type plasminogen activator (uPA) and its receptor (uPAR): diagnostic, prognostic, and therapeutic applications","volume":"8","author":"Mahmood","year":"2018","unstructured":"Mahmood N, Mihalcioiu C and Rabbani SA. Multifaceted role of the urokinase-type plasminogen activator (uPA) and its receptor (uPAR): diagnostic, prognostic, and therapeutic applications. Front Oncol 2018; 8: 24.","journal-title":"Front Oncol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13046-019-1156-5","article-title":"ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa\/VEGFR2\/ERK pathway","volume":"38","author":"Zhang","year":"2019","unstructured":"Zhang Q, Lu S, Li T, Yu L, Zhang Y, Zeng H, Qian X, Bi J and Lin Y. ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa\/VEGFR2\/ERK pathway. J Exp Clin Cancer Res 2019; 38: 173.","journal-title":"J Exp Clin Cancer Res"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-3-030-51652-9_17","article-title":"HIF-1α metabolic pathways in human cancer","volume":"1280","author":"Elzakra","year":"2021","unstructured":"Elzakra N and Kim Y. HIF-1α metabolic pathways in human cancer. Adv Exp Med Biol 2021; 1280: 243-260.","journal-title":"Adv Exp Med Biol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2020.05.002","article-title":"Hypoxia and cancer related pathology","volume":"486","author":"Xiong","year":"2020","unstructured":"Xiong Q, Liu B, Ding M, Zhou J, Yang C and Chen Y. Hypoxia and cancer related pathology. Cancer Lett 2020; 486: 1-7.","journal-title":"Cancer Lett"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.euf.2021.08.006","article-title":"The value of preoperative plasma VEGF levels in urothelial carcinoma of the bladder treated with radical cystectomy","volume":"8","author":"Mori","year":"2022","unstructured":"Mori K, Schuettfort VM, Katayama S, Laukhtina E, Pradere B, Quhal F, Sari Motlagh R, Mostafaei H, Grossmann NC, Rajwa P, König F, Aydh A, Soria F, Moschini M, Karakiewicz PI, Lotan Y, Scherr D, Haydter M, Nyirady P, Teoh JYC, Egawa S, Compérat E and Shariat SF. The value of preoperative plasma VEGF levels in urothelial carcinoma of the bladder treated with radical cystectomy. Eur Urol Focus 2022; 8: 972-979.","journal-title":"Eur Urol Focus"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.3748\/wjg.v18.i15.1781","article-title":"Glycer-AGEs-RAGE signaling enhances the angiogenic potential of hepatocellular carcinoma by upregulating VEGF expression","volume":"18","author":"Takino","year":"2012","unstructured":"Takino J, Yamagishi S and Takeuchi M. Glycer-AGEs-RAGE signaling enhances the angiogenic potential of hepatocellular carcinoma by upregulating VEGF expression. World J Gastroenterol 2012; 18: 1781-1788.","journal-title":"World J Gastroenterol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cca.2014.04.027","article-title":"Expression of vascular endothelial growth factor (VEGF) in patients with oral squamous cell carcinoma and its clinical significance","volume":"436","author":"Aggarwal","year":"2014","unstructured":"Aggarwal S, Devaraja K, Sharma SC and Das SN. Expression of vascular endothelial growth factor (VEGF) in patients with oral squamous cell carcinoma and its clinical significance. Clin Chim Acta 2014; 436: 35-40.","journal-title":"Clin Chim Acta"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1097\/MEG.0b013e3283484795","article-title":"Epidemiology of cancer from the oral cavity and oropharynx","volume":"23","author":"Lambert","year":"2011","unstructured":"Lambert R, Sauvaget C, de Camargo Cancela M and Sankaranarayanan R. Epidemiology of cancer from the oral cavity and oropharynx. Eur J Gastroenterol Hepatol 2011; 23: 633-641.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.oraloncology.2014.04.010","article-title":"Clinical evidence of field cancerization in patients with oral cavity cancer in a betel quid chewing area","volume":"50","author":"Liao","year":"2014","unstructured":"Liao CT, Wallace CG, Lee LY, Hsueh C, Lin CY, Fan KH, Wang HM, Ng SH, Lin CH, Tsao CK, Chen IH, Huang SF, Kang CJ and Yen TC. Clinical evidence of field cancerization in patients with oral cavity cancer in a betel quid chewing area. Oral Oncol 2014; 50: 721-731.","journal-title":"Oral Oncol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3233\/CBM-190067","article-title":"Combined detection of CA19-9 and B7-H4 in the diagnosis and prognosis of pancreatic cancer","volume":"25","author":"Xu","year":"2019","unstructured":"Xu X, Xiao Y, Hong B, Hao B and Qian Y. Combined detection of CA19-9 and B7-H4 in the diagnosis and prognosis of pancreatic cancer. Cancer Biomark 2019; 25: 251-257.","journal-title":"Cancer Biomark"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.1038\/s41467-020-17525-6","article-title":"Therapeutic paradigm of dual targeting VEGF and PDGF for effectively treating FGF-2 off-target tumors","volume":"11","author":"Hosaka","year":"2020","unstructured":"Hosaka K, Yang Y, Seki T, Du Q, Jing X, He X, Wu J, Zhang Y, Morikawa H, Nakamura M, Scherzer M, Sun X, Xu Y, Cheng T, Li X, Liu X, Li Q, Liu Y, Hong A, Chen Y and Cao Y. Therapeutic paradigm of dual targeting VEGF and PDGF for effectively treating FGF-2 off-target tumors. Nat Commun 2020; 11: 3704.","journal-title":"Nat Commun"}],"container-title":["International Journal of Clinical and Experimental Pathology"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ijcep\/18\/1\/ijcep0155806.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:55:42Z","timestamp":1766022942000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ijcep\/18\/1\/ijcep0155806.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/cxdc6773","relation":{},"ISSN":["1936-2625"],"issn-type":[{"value":"1936-2625","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}